Skip to main content
    D

    Dermata Therapeutics Inc (DRMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.57
    -0.03 (-4.75%)

    Market Cap: $3.06M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Dermata Therapeutics Inc (DRMA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Dermata Therapeutics (DRMA) has a market cap of $3.06M. It kept -12811.49% of revenue as net income over the last 12 months. Its share count is up 398.76% from a year earlier.

    Total Valuation

    Market Cap$3.06M
    Latest price (Nov 17, 2026)$0.57

    Key Dates

    The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 24, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 27.28% in the quarter ended Sep 30, 2026 and grew 473.85% a year over 2 years.

    Shares Outstanding5.12M
    Shares Change (YoY)+398.76%
    Shares Change (QoQ)+27.28%
    Share Count Growth (2Y CAGR)+473.85%

    Valuation Ratios

    Sales and book value multiples are 39.4x and 0.7x.

    P/S Ratio39.4x
    Forward P/S30.6x
    P/B Ratio0.7x

    Price Statistics

    The stock is down 81.43% over 52 weeks and trades 39.36% below its 50-day average.

    Beta (1Y)1.22
    52-Week Change-81.43%
    1-Month Change-33.70%
    3-Month Change-61.22%
    6-Month Change-51.69%
    5-Year Change-99.99%
    Total Return (1Y)-81.43%
    Total Return (3Y CAGR)-82.42%
    Total Return (5Y CAGR)-86.22%
    Max Drawdown (1Y)-81.84%
    Max Drawdown (3Y)-99.54%
    Sharpe Ratio (1Y)-1.23
    Correlation with SPY (1Y)0.13
    50-Day Average$0.94
    200-Day Average$1.22
    52-Week Range$0.57 to $3.16
    RSI (14 Days)30.7
    Average Volume (20 Days)102.59K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.36x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.36x
    Quick Ratio2.05x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -243.17% and return on assets is -143.14% over the last 12 months.

    Return on Equity (ROE)-243.17%
    Return on Assets (ROA)-143.14%
    ROIC (5Y Average)-96.74%
    Asset Turnover0.01x
    Inventory Turnover0.07x

    Scores

    DRMA has an Altman Z-Score of -20.56, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-20.56
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $74.14K over the last 12 months.

    Revenue$74.14K
    Operating Income-$9.70M
    Pretax Income-$9.50M
    Net Income-$9.50M
    Reported EPS (TTM)-$3.29

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 58.89% of the $6.64M in total assets.

    Cash and Equivalents$4.82M
    Total Debt$0
    Net Cash$4.82M
    Net Cash Per Share$0.94
    Working Capital$3.70M
    Shareholder Equity$3.91M
    Book Value Per Share$0.76
    Total Assets$6.64M
    Total Liabilities$2.73M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$8.88M
    FCF Per Share-$1.80

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -13082.32%.

    Operating Margin-13082.32%
    Pretax Margin-12811.49%
    Net Margin-12811.49%

    Dividends and Yields

    DRMA does not pay a dividend.

    Buyback Yield-322.14%
    Shareholder Yield-322.14%

    Stock Splits

    The last split was a 1-for-10 reverse split on Aug 1, 2025.

    Last Split DateAug 1, 2025
    Split TypeReverse split
    Split Ratio1:10

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About DRMA

    What is DRMA's market cap?

    Dermata Therapeutics has a market cap of $3.06M.

    How many shares of DRMA are outstanding?

    Dermata Therapeutics has 5.12M shares outstanding. The count is up 398.76% from a year earlier.

    Does DRMA pay a dividend?

    No. Dermata Therapeutics does not pay a dividend.

    How much debt does DRMA have?

    Dermata Therapeutics has $0 of total debt and $4.82M of cash and equivalents, a net cash position of $4.82M.